Trial: Safety and acceptability of dapivirine gel, conducted using daily monitored adherence in healthy HIV-negative women [IPM 014A]
Phase: I/II
Product Being Tested: Dapivirine gel
Sponsor, funder, developer, collaborator: International Partnership for Microbicides, Johns Hopkins Project, College of Medicine
Total participants: 320
Countries: Kenya, Malawi, Rwanda, South Africa
Trial sites in Malawi:Blantyre
Results expected: n/a
For more information: http://clinicaltrials.gov/ct2/show/NCT00917904?term=IPM014B&rank=1
Trial: Dapivirine vaginal ring safety [IPM 015]
Phase: I/II
Product Being Tested: Dapivirine vaginal ring
Sponsor, funder, developer, collaborator: International Partnership for Microbicides
Total participants: 280
Countries: South Africa, Kenya, Malawi, Rwanda, Tanzania
Results expected: n/a
For more information: http://www.clinicaltrials.gov/ct2/show/NCT01071174?term=dapivirine+vaginal+ring&rank=1
Trial: VOICE (MTN 003)
Phase: IIb, safety and effectiveness
Product being tested: Tenofovir gel; oral TDF; oral TDF/FTC
Sponsor, funder, developer, collaborator: CONRAD, DAIDS/NIAID, Gilead, MTN, NICHD, NIMH
Total participants: 5,000 heterosexual women
Countries: Malawi, South Africa, Uganda, Zimbabwe
Results expected: Ongoing/2013